FDA Approves Leqembi, Extending Alzheimer's Treatment to More Patients




Medicare enrollees can get the anti-amyloid treatment as a result of the agency’s full approval.




Medicare enrollees can get the anti-amyloid treatment as a result of the agency’s full approval.

FOLLOW US ON GOOGLE NEWS

Read original article here

Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – admin@technoblender.com. The content will be deleted within 24 hours.
4523.TOAlvaro Pascual-LeoneAlzheimer's DiseaseAlzheimer039sApprovesArt NagleBIIBBiogenBusinessC&E Industry News FilterContent TypescorporateCorporate/Industrial NewsdementiaEconomyEisaiEli LillyextendingFactiva FiltersFDAFinancial Servicesgeneral newsgovernment policyGovernment Sponsored Health InsuranceHealthHealth/Medical InsurancehealthcareHealthcare/Life Sciencesindustrial newsinsuranceJason KarlawishJay ReinsteinJeffrey BurnsJP:4523Julio RojasLeqembilife sciencesLLYMedical Conditionsmedical insurancemedical treatmentsMedical Treatments/ProceduresMedicationsMental DisordersNeurodegenerative Disease Drugsnew productsNew Products/ServicesNon-life InsurancePaige NaglePatientsPharmaceuticalspoliticalPolitical/General NewsproceduresProductProduct/Service ApprovalsProductsProducts/ServicesregulationRegulation/Government Policyservice approvalsServicesspecialized drugsSpecialized Drugs/MedicationsSYNDTechnoblenderTeresa BuracchiotreatmentWSJ-PRO-WSJ.comwsjhealth
Comments (0)
Add Comment